177 related articles for article (PubMed ID: 38321194)
1. Healthcare consumer acceptability of routine use of the EQ-5D-5L in clinical care: a cross-sectional survey.
Snowdon DA; Collyer TA; Marsh L; Srikanth V; Beare R; Baber S; Naude K; Andrew NE
Qual Life Res; 2024 May; 33(5):1307-1321. PubMed ID: 38321194
[TBL] [Abstract][Full Text] [Related]
2. Acceptability of the routine use and collection of a generic patient reported outcome measure from the perspective of healthcare staff: a qualitative study.
Snowdon DA; Srikanth V; Beare R; Noeske KE; Le E; O'Bree B; Andrew NE
J Patient Rep Outcomes; 2023 Jul; 7(1):81. PubMed ID: 37522943
[TBL] [Abstract][Full Text] [Related]
3. Comparing the measurement equivalence of EQ-5D-5L across different modes of administration.
Mulhern B; O'Gorman H; Rotherham N; Brazier J
Health Qual Life Outcomes; 2015 Nov; 13():191. PubMed ID: 26612336
[TBL] [Abstract][Full Text] [Related]
4. Is the EQ-5D fit for purpose in asthma? Acceptability and content validity from the patient perspective.
Whalley D; Globe G; Crawford R; Doward L; Tafesse E; Brazier J; Price D
Health Qual Life Outcomes; 2018 Aug; 16(1):160. PubMed ID: 30075729
[TBL] [Abstract][Full Text] [Related]
5. Measuring health-related quality of life in chronic obstructive pulmonary disease: properties of the EQ-5D-5L and PROMIS-43 short form.
Lin FJ; Pickard AS; Krishnan JA; Joo MJ; Au DH; Carson SS; Gillespie S; Henderson AG; Lindenauer PK; McBurnie MA; Mularski RA; Naureckas ET; Vollmer WM; Lee TA;
BMC Med Res Methodol; 2014 Jun; 14():78. PubMed ID: 24934150
[TBL] [Abstract][Full Text] [Related]
6. Acceptability of the health-related quality of life instrument EQ-5D-Y-5L among patients in child and adolescent psychiatric inpatient care.
Krig S; Åström M; Kulane A; Burström K
Acta Paediatr; 2021 Mar; 110(3):899-906. PubMed ID: 32815186
[TBL] [Abstract][Full Text] [Related]
7. Validity of an enhanced EQ-5D-5L measure with an added cognitive dimension in patients with stroke.
de Graaf JA; Kuijpers M; Visser-Meily J; Kappelle LJ; Post M
Clin Rehabil; 2020 Apr; 34(4):545-550. PubMed ID: 32070131
[TBL] [Abstract][Full Text] [Related]
8. EQ-5D-Y-5L as a patient-reported outcome measure in psychiatric inpatient care for children and adolescents - a cross-sectional study.
Åström M; Krig S; Ryding S; Cleland N; Rolfson O; Burström K
Health Qual Life Outcomes; 2020 Jun; 18(1):164. PubMed ID: 32493419
[TBL] [Abstract][Full Text] [Related]
9. An empirical comparison of the measurement properties of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U for older people in residential care.
Easton T; Milte R; Crotty M; Ratcliffe J
Qual Life Res; 2018 May; 27(5):1283-1294. PubMed ID: 29305782
[TBL] [Abstract][Full Text] [Related]
10. Response process validity of three patient reported outcome measures for people requiring kidney care: a think-aloud study using the EQ-5D-5L, ICECAP-A and ICECAP-O.
Mitchell PM; Caskey FJ; Scott J; Sanghera S; Coast J
BMJ Open; 2020 May; 10(5):e034569. PubMed ID: 32414822
[TBL] [Abstract][Full Text] [Related]
11. Population Norms for the EQ-5D-5L, PROPr and SF-6D in Hungary.
Nikl A; Janssen MF; Jenei B; Brodszky V; Rencz F
Pharmacoeconomics; 2024 May; 42(5):583-603. PubMed ID: 38416366
[TBL] [Abstract][Full Text] [Related]
12. The use of EQ-5D-5L as a patient-reported outcome measure in evaluating community rehabilitation services in Alberta, Canada.
Short H; Al Sayah F; Churchill K; Keogh E; Warner L; Ohinmaa A; Johnson JA
Health Qual Life Outcomes; 2023 Nov; 21(1):125. PubMed ID: 37978502
[TBL] [Abstract][Full Text] [Related]
13. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
[TBL] [Abstract][Full Text] [Related]
14. Use of EQ-5D-5L for Assessing Patient-Reported Outcomes in a National Register for Specialized Rehabilitation.
Garratt AM; Engen K; Kjeldberg IR; Nordvik JE; Ringheim I; Westskogen L; Becker F
Arch Phys Med Rehabil; 2024 Jan; 105(1):40-48. PubMed ID: 37236496
[TBL] [Abstract][Full Text] [Related]
15. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
[TBL] [Abstract][Full Text] [Related]
16. Understanding the measurement relationship between EQ-5D-5L, PROMIS-29 and PROPr.
Mulhern BJ; Pan T; Norman R; Tran-Duy A; Hanmer J; Viney R; Devlin NJ
Qual Life Res; 2023 Nov; 32(11):3147-3160. PubMed ID: 37347395
[TBL] [Abstract][Full Text] [Related]
17. Population norms for the EQ-5D-3L and EQ-5D-5L in Romania.
Olariu E; Caplescu R; Vale L; Niculescu-Aron IG; Oluboyede Y; Paveliu MS
Health Qual Life Outcomes; 2023 Jul; 21(1):80. PubMed ID: 37507760
[TBL] [Abstract][Full Text] [Related]
18. Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey.
Jankowska A; Młyńczak K; Golicki D
Health Qual Life Outcomes; 2021 May; 19(1):138. PubMed ID: 33952271
[TBL] [Abstract][Full Text] [Related]
19. Population norms of health-related quality of life in Moscow, Russia: the EQ-5D-5L-based survey.
Hołownia-Voloskova M; Tarbastaev A; Golicki D
Qual Life Res; 2021 Mar; 30(3):831-840. PubMed ID: 33237551
[TBL] [Abstract][Full Text] [Related]
20. Cross-cultural measurement equivalence of the 5-level EQ-5D (EQ-5D-5L) in patients with type 2 diabetes mellitus in Singapore.
Wang Y; Tan NC; Tay EG; Thumboo J; Luo N
Health Qual Life Outcomes; 2015 Jul; 13():103. PubMed ID: 26179285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
